"Alabama Medical Group, P.C. has provided state-of-the-art healthcare to patients since 1946. As the largest independently-owned multispecialty physician clinic in Mobile, Alabama, our healthcare team takes great pride in creating an environment where patients receive quality, individualized and compassionate medical care."

During the past decade, Internal Medicine Center, LLC conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 16 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Internal Medicine Center, LLC" #1 sponsor was "Allergan" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Internal Medicine Center, LLC" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Insulet Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Internal Medicine Center, LLC" are "Gastroparesis" (4 trials), "Ulcerative Colitis" (4 trials), "Diabetes Mellitus" (3 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "Internal Medicine Center, LLC" in a lesser frequency.

Most popular intervention types in "Internal Medicine Center, LLC" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Relamorelin" (3 trials), "CP-690,550" (2 trials), "placebo" (2 trials) and "B/F/TAF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Internal Medicine Center, LLC" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Internal Medicine Center, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Internal Medicine Center, LLC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Internal Medicine Center, LLC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".